Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis clinical trial (NCT02598934). Contact the study team or your healthcare provider for specific answers.

Question 2

How does ibandronate compare to other osteoporosis treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis clinical trial (NCT02598934). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of while taking ibandronate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis clinical trial (NCT02598934). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis clinical trial (NCT02598934). Contact the study team or your healthcare provider for specific answers.

Question 5

What tests or monitoring will be involved in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis clinical trial (NCT02598934). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects or my condition changes during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis clinical trial (NCT02598934). Contact the study team or your healthcare provider for specific answers.

What this study is about